375 results on '"Bergmann, Martin W."'
Search Results
102. New technical and anticoagulation aspects for left atrial appendage closure using the WATCHMAN® device in patients not taking warfarin
103. Response to Letter Regarding Article, “Percutaneous Left-Ventricular Support With the Impella-2.5-Assist Device in Acute Cardiogenic Shock Results of the Impella-EUROSHOCK-Registry”
104. New Concepts for Sympathetic Renal Artery Denervation: Review of Existing Literature and Case Report
105. The Four and a Half LIM-Domain 2 Controls Early Cardiac Cell Commitment and Expansion Via Regulating β-Catenin-Dependent Transcription
106. Percutaneous Left-Ventricular Support With the Impella-2.5–Assist Device in Acute Cardiogenic Shock
107. EWOLUTION: Design of a registry to evaluate real-world clinical outcomes in patients with AF and high stroke risk-treated with the WATCHMAN left atrial appendage closure technology.
108. Implant success and safety of left atrial appendage closure with theWATCHMAN device: peri-procedural outcomes from the EWOLUTION registry.
109. Abstract 19135: Safety and Efficacy of Intramyocardial Delivery of Stem Cells in Ischemic Heart Failure: An Individual Patient Data-Based Meta-Analysis
110. Percutaneous, transendocardial injection of bone marrow-derived mononuclear cells in heart failure patients following acute ST-elevation myocardial infarction: ALSTER-Stem Cell trial
111. Abstract 238: Role of Erythropoietin Signaling in the Biology of Mouse Cardiac Progenitor Cells
112. Abstract 356: Krueppel-Like Factor 15 Regulates Wnt/β-Catenin Transcription and Controls Cardiac Progenitor Cell Fate in the Postnatal Heart
113. WNT Signaling in Adult Cardiac Hypertrophy and Remodeling
114. Wnt Signaling Molecules in Left Ventricular Remodeling
115. Glucocorticoids inhibit IL-1β-induced GM-CSF expression at multiple levels: roles for the ERK pathway and repression by MKP-1
116. MEF2 transcriptional activity maintains mitochondrial adaptation in cardiac pressure overload
117. RALT Specifically Halts Maladaptive Cardiac Hypertrophy
118. Treatment-Sensitive Premature Renal and Heart Senescence in Hypertension
119. Role of β-Catenin in Adult Cardiac Remodeling
120. Linking Cardiac Mechanosensing at the Sarcomere M-Band, Nuclear Factor κB Signaling, and Cardiac Remodeling
121. Requirement of Nuclear Factor-κB in Angiotensin II– and Isoproterenol-Induced Cardiac Hypertrophy In Vivo
122. Reoxygenation after severe hypoxia induces cardiomyocyte hypertrophy in vitro: activation of CREB downstream of GSK3β
123. Nuclear factor-kappaB does not mediate the inhibitory effects of dexamethasone on granulocyte-macrophage colony-stimulating factor expression
124. Inhibitors of Protein Kinase C (PKC) Prevent Activated Transcription
125. IL-1β-dependent activation of NF-κB mediates PGE2release via the expression of cyclooxygenase-2 and microsomal prostaglandin E synthase
126. In Cardiomyocyte Hypoxia, Insulin-Like Growth Factor-I-Induced Antiapoptotic Signaling Requires Phosphatidylinositol-3-OH-Kinase-Dependent and Mitogen-Activated Protein Kinase-Dependent Activation of the Transcription Factor cAMP Response Element-Binding Protein
127. GM-CSF Expression in Pulmonary Epithelial Cells Is Regulated Negatively by Posttranscriptional Mechanisms
128. A pilot study of chronic, low-dose epoetin-{beta} following percutaneous coronary intervention suggests safety, feasibility, and efficacy in patients with symptomatic ischaemic heart failure.
129. Role of β-Catenin in Adult Cardiac Remodeling.
130. β-Catenin Downregulation Is Required for Adaptive Cardiac Remodeling.
131. Requirement of nuclear factor-kappaB in angiotensin II- and isoproterenol-induced cardiac hypertrophy in vivo.
132. IL-1β-dependent activation of NF-κB mediates PGE2 release via the expression of cyclooxygenase-2 and microsomal prostaglandin E synthase
133. Latent Pulmonary Vascular Disease May Alter the Response to Therapeutic Atrial Shunt Device in Heart Failure.
134. Linking cardiac mechanosensing at the sarcomere M-band, nuclear factor kappaB signaling, and cardiac remodeling.
135. Reoxygenation after severe hypoxia induces cardiomyocyte hypertrophy in vitro: activation of CREB downstream of GSK3β.
136. Evaluating Real-World Clinical Outcomes in Atrial Fibrillation Patients Receiving the WATCHMAN Left Atrial Appendage Closure Technology: Final 2-Year Outcome Data of the EWOLUTION Trial Focusing on History of Stroke and Hemorrhage.
137. Inhibitors of protein kinase C (PKC) prevent activated transcription: role of events downstream of NF-kappaB DNA binding
138. IL-1beta-dependent activation of NF-kappaB mediates PGE2 release via the expression of cyclooxygenase-2 and microsomal prostaglandin E synthase
139. Glucocorticoids inhibit IL-1beta-induced GM-CSF expression at multiple levels: roles for the ERK pathway and repression by MKP-1.
140. Heart-Restricted NF-κB Inhibition Abrogates Left Ventricular Remodeling after Transaortic Banding.
141. Higher in-hospital mortality in SARS-CoV-2 omicron variant infection compared to influenza infection—Insights from the CORONA Germany study.
142. Results of the ALSTER CTO-OCT registry: Delayed DES endothelialization after subintimal recanalization of chronic of total occlusion: Observation by optical coherence tomography.
143. Effect of allogeneic adipose tissue‐derived mesenchymal stromal cell treatment in chronic ischaemic heart failure with reduced ejection fraction – the SCIENCE trial.
144. Abstract 356.
145. Abstract 238.
146. Mice with Heart-Restricted β-Catenin Deletion Develop a Modest Cardiac Hypertrophic Phenotype but a Normal Hypertrophic Response to Angiotensin II.
147. Amplatzer Amulet Implantation: Case Series
148. Amplatzer Amulet Implantation
149. Anatomy and Imaging of the LAA
150. Impella Support for Acute Myocardial Infarction complicated by Cardiogenic Shock: A Matched-Pair IABP-SHOCK II Trial 30-Day Mortality Analysis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.